EUVIMEDEUVIMED entdecken
Crossref

Hepatocellular Carcinoma-Targeted Icariside II Nanomicelles: Engineering a Glycyrrhetinic Acid-Modified Copolymer Platform for Enhanced Tumor Therapy

Zheng Sun, Zhiyong Li, Teng Hao, Xuecun Liu, Yuanyuan Jiang, Songyuge Ping, Na Dong, Ruiling Guo, Xin Yang iD, Hui Xu iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zheng Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of…. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid, Carcinoma, Hepatocellular, Liver Neoplasms, Polymers. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Department of Science and Technology of Shandong Province, Graduate Innovation Foundation of Yantai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide, accounting for about 90% of all primary liver malignancies. The emergence of natural antitumor compounds provides a new strategy for the treatment of HCC, but their delivery in vivo has become a major problem. In this study, the copolymer of the natural product glycyrrhetinic acid (AMGA) was prepared and served as a carrier for encapsulation of the natural active ingredient Icariside II (AMGA@ICAII). The results show that AMGA still retains the interaction with GA-R and achieves active targeting by interacting with GA-R. In addition, GA-modification changes the physical chemistry nature of the carrier, providing it with better colloidal stability. AMGA@ICAII significantly inhibited the proliferation of the human hepatoma cell line HepG-2 in vitro compared with other treatment groups. Furthermore, AMGA@ICAII improved the distribution of ICAII in the C57BL/6J mouse Hepa1-6 hepatoma model and showed a significant antitumor effect. This work demonstrated that small molecule target modification in the hydrophobic segment of block copolymer will do benefit to improve the performance of the carrier, while retaining ligand-receptor-mediated targeting properties and providing a reference for the targeted delivery of anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhetinic AcidCarcinoma, HepatocellularLiver NeoplasmsPolymersNanoparticlesAnimalsHumansMiceMicellesHep G2 CellsCell Line, TumorMice, Inbred C57BLDrug CarriersCell ProliferationAntineoplastic AgentsMale

Stichwörter der Autor:innen

active targetingantihepatocellular carcinomaglycyrrhetinic acidicariside II

Substanzen

Glycyrrhetinic AcidMicellesPolymersDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Minis…
  • Yantai Dongcheng Pharmaceutical Group Co., Ltd., Yantai 264006, China.
  • School of Food and Biological Engineering, Yantai Institute of Technology, Yantai 264003, China.
  • School of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.

ORCID-Profile: Xin Yang, Hui Xu

Förderung

  • Department of Science and Technology of Shandong Province
  • Graduate Innovation Foundation of Yantai University

Zitieren

APA

Sun, Z., Li, Z., Hao, T., Liu, X., Jiang, Y., Ping, S., Dong, N., Guo, R., Yang, X., & Xu, H. (2025). Hepatocellular Carcinoma-Targeted Icariside II Nanomicelles: Engineering a Glycyrrhetinic Acid-Modified Copolymer Platform for Enhanced Tumor Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00461

Vancouver

Sun Z, Li Z, Hao T, Liu X, Jiang Y, Ping S, et al. Hepatocellular Carcinoma-Targeted Icariside II Nanomicelles: Engineering a Glycyrrhetinic Acid-Modified Copolymer Platform for Enhanced Tumor Therapy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00461

BibTeX
@article{Sun2025,
  author = {Sun, Zheng and Li, Zhiyong and Hao, Teng and Liu, Xuecun and Jiang, Yuanyuan and Ping, Songyuge and Dong, Na and Guo, Ruiling and Yang, Xin and Xu, Hui},
  title = {Hepatocellular Carcinoma-Targeted Icariside II Nanomicelles: Engineering a Glycyrrhetinic Acid-Modified Copolymer Platform for Enhanced Tumor Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00461}
}
Kostenlos starten →